Statement of Use

PTO- 1553

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1553

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:
MARK: BLUETRACE BY BLUEBIRD BIO(Standard Characters, see http://uspto.report/TM/97026358/mark.png)
SERIAL NUMBER: 97026358


OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
bluebird bio, Inc., having an address of
      455 Grand Union Blvd
      Somerville, Massachusetts 02145
      United States
      Email: XXXX


The owner is submitting the following allegation of use information:

For International Class 042:
Current identification: Providing online non-downloadable software for documenting data on the sourcing, manufacturing, packaging, storage, transport, and delivery of materials for use in therapies and therapeutics

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 02/09/2024, and first used in commerce at least as early as 02/09/2024, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) Webpages.

Original PDF file:
SPN0-1-40143209162-202402 12114109983162_._5309.009 2-001__Specimen_of_Use_1.pdf
Converted PDF file(s) (1 page)
Specimen File1
Original PDF file:
SPN0-1-40143209162-202402 12114109983162_._5309.009 2-001__Specimen_of_Use_2.pdf
Converted PDF file(s) (1 page)
Specimen File1
Original PDF file:
SPN0-1-40143209162-202402 12114109983162_._5309.009 2-001__Specimen_of_Use_3.pdf
Converted PDF file(s) (1 page)
Specimen File1
Original PDF file:
SPN0-1-40143209162-202402 12114109983162_._5309.009 2-001__Specimen_of_Use_4.pdf
Converted PDF file(s) (1 page)
Specimen File1
Original PDF file:
SPN0-1-40143209162-202402 12114109983162_._5309.009 2-001__Specimen_of_Use_5.pdf
Converted PDF file(s) (1 page)
Specimen File1
Original PDF file:
SPN0-1-40143209162-202402 12114109983162_._5309.009 2-001__Specimen_of_Use_6.pdf
Converted PDF file(s) (1 page)
Specimen File1
Original PDF file:
SPN0-1-40143209162-202402 12114109983162_._5309.009 2-001__Specimen_of_Use_7.pdf
Converted PDF file(s) (1 page)
Specimen File1
Original PDF file:
SPN0-1-40143209162-202402 12114109983162_._5309.009 2-001__Specimen_of_Use_8.pdf
Converted PDF file(s) (1 page)
Specimen File1
Original PDF file:
SPN0-1-40143209162-202402 12114109983162_._5309.009 2-001__Specimen_of_Use_9.pdf
Converted PDF file(s) (1 page)
Specimen File1

Webpage URL: serviceportal.bluebirdbio.com
Webpage Date of Access: 02/09/2024
Webpage URL: bbbpartnerservices.my.site.com/qtcportal/s/
Webpage Date of Access: 02/09/2024
Webpage URL: bbbpartnerservices.my.site.com/qtcportal/s/to-do
Webpage Date of Access: 02/09/2024
Webpage URL: bbbpartnerservices.my.site.com/qtcportal/s/enroll-patient
Webpage Date of Access: 02/09/2024
Webpage URL: bbbpartnerservices.my.site.com/qtcportal/s/schedule-collection
Webpage Date of Access: 02/09/2024
Webpage URL: bbbpartnerservices.my.site.com/qtcportal/s/collection-labels-and-shipping
Webpage Date of Access: 02/09/2024
Webpage URL: bbbpartnerservices.my.site.com/qtcportal/s/infusion
Webpage Date of Access: 02/09/2024
Webpage URL: bbbpartnerservices.my.site.com/qtcportal/s/resources
Webpage Date of Access: 02/09/2024
Webpage URL: bbbpartnerservices.my.site.com/qtcportal/s/contact-bluebird-bio
Webpage Date of Access: 02/09/2024

The applicant is not filing a Request to Divide with this Allegation of Use form. Correspondence Information
      Christopher K. Albert
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@hbsr.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): christopher.albert@hbsr.com

The docket/reference number is 5309.0092001.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $100 will be submitted with the form, representing payment for the allegation of use for 1 class.


Declaration

	The signatory believes that the applicant is the owner of the mark sought to be registered. For a trademark or service mark application, the mark is in use in commerce on or in connection with all the goods/services in the application or notice of allowance, or as subsequently modified. For a collective trademark, collective service mark, collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or in connection with all the goods/services/collective membership organization in the application or notice of allowance, or as subsequently modified. For a certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the all goods/services in the application or notice of allowance, or as subsequently modified, and the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.
	The specimen(s) shows the mark as used on or in connection with the goods/services/collective membership organization in commerce.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Signature: /Lynn Zuchowski/      Date Signed: 02/12/2024
Signatory's Name: Lynn Zuchowski
Signatory's Position: Vice President, Chief Counsel, Severe Genetic Diseases
Signatory's Phone: 6177717072
Signature method: Sent to third party for signature

PAYMENT: 97026358
PAYMENT DATE: 02/12/2024

Serial Number: 97026358
Internet Transmission Date: Mon Feb 12 14:59:30 ET 2024
TEAS Stamp: USPTO/SOU-XX.XXX.XXX.XX-2024021214593091
5571-97026358-850101cbdfe9d9ed2bd92e8617
75deae23de941e326e24b32492155e86aad941-D
A-59309842-20240212120403690632